The Critical Role of the Ubiquitin-Proteasome Pathway in Muscle Wasting in Comparison to Lysosomal and Ca2+-Dependent Systems

Advances in Molecular and Cell Biology

Volumn 27, Issue C, 1998, Pages 235-266

  Attaix, Didier ^a   Taillandier, Daniel ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956783904     PISSN: 15692558     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-2558(08)60463-4     Document Type: Article

References (129)

1. Ahn J.Y., Tanahashi N., Akiyama K., Hisamatsu H., Noda C., Tanaka K., Chung C.H., Shibmara N., Willy P.J., Mott J.D., Slaughter C.A., and DeMartino G.N. Primary structures of two homologous subunits of PA28, a γ-interferon-inducible protein activator of the 20S proteasome. FEBS Lett. 366 (1995) 37-42
2. Attaix D., Taillandier D., Combaret L., Ralliére C., Larbaud D., Aurousseau E., and Tanaka K. Expression of subunits of the 19S complex and of the PA28 activator in rat skeletal muscle. Mol. Biol. Rep. 24 (1997) 95-98
3. Attaix D., Taillandier D., Temparis S., Larbaud D., Aurousseau E., Combaret L., and Voisin L. Regulation of ATP-ubiquitin-dependent proteolysis in muscle wasting. Reprod. Nutr. Dev. 34 (1994) 583-597
4. Auclair D., Garrel D.R., Zerouala A.C., and Ferland L.H. Activation of the ubiquitin pathway in rat skeletal muscle by catabolic doses of glucocorticoids. Am. J. Physiol. 272 (1997) C1007-C1016
5. Bailey J.L., Wang W., England B.K., Price S.R., Ding X., and Mitch W.E. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. J. Clin. Invest. 97 (1996) 1447-1453
6. Ball E., Karlik C.C., Beall C.J., Saville D.L., Sparrow J.C., Bullard B., and Fyrberg E.A. Arthrin, a myofibrillar protein of insect flight muscle, is an actin-ubiquitin conjugate. Cell 51 (1987) 221-228
7. Baracos V.E., DeVivo C., Hoyle D.H.R., and Goldberg A.L. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. Am. J. Physiol. 268 (1995) E996-E1006
8. Baracos V.E., Rodemann H.P., Dinarello C.A., and Goldberg A.L. Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). N. Engl. J. Med. 308 (1983) 553-558
9. Barrett E.J., and Gelfand R.A. The in vivo study of cardiac and skeletal muscle protein turnover. Diabetes Metab. Rev. 5 (1989) 133-148
10. Barrett E.J., Jahn L.A., Oiveras D.M., and Friburg D.A. Chloroquine does not exert insulin-like actions on human forearm muscle metabolism. Am. J. Physiol. 268 (1995) E820-E824
11. Baumeister W., Walz J., Zühl F., and Seemüller E. The proteasome: Paradigm of a self-conpartmentalizing protease. Cell 92 (1998) 367-380
12. Belkhou R., Béchet D., Cherel Y., Galluser M., Ferrara M., and Le Maho Y. Effects of fasting and thyroidectomy on cysteine proteinase activities in liver and muscle. Biochim. Biophys. Acta 1199 (1994) 195-201
13. Botbol V., and Scomick O.A. Measurement of muscle protein degradation in live mice by accumulation of bestatin-induced peptides. Am. J. Physiol. 273 (1997) E1149-E1157
14. Breuillé, Farges M.C.D., Rosé F., Arnal M., Attaix D., and Obled C. Pentoxifylline decreases body weight loss and muscle protein wasting characteristics of sepsis. Am. J. Physiol. 265 (1993) E660-E666
15. Carillo S., Pariat M., Jariel-Encontre I., Poulat F., Berta P., and Piechaczyk M. PEST motifs are not required for rapid calpain-mediated proteolysis of c-fos protein. Biochem. J. 313 (1996) 245-251
16. Combaret L., Taillandier D., Voisin L., Samuels S.E., Boespflug-Tanguy O., and Attaix D. No alteration in gene expression of components of the ubiquitin-proteasome proteolytic pathway in dystrophin-deficient muscles. FEBS Lett. 393 (1996) 292-296
17. 2-adrenergic agonist (clenbuterol): role of the ubiquitin-energy-dependent pathway. J. Clin. Invest. 95 (1995) 2367-2372
18. Coux O., Tanaka K., and Goldberg A.L. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65 (1996) 801-847
19. Croall D.E., and DeMartino G.N. Calcium-activated neutral protease (calpain) system: structure, function, and regulation. Physiol. Rev. 71 (1991) 813-847
20. Dahlmann B., and Kuehn L. The 20S/26S proteasomal pathway of protein degradation in muscle tissue. Mol. Biol. Rep. 21 (1995) 57-62
21. Dahlmann B., Kuehn L., and Reinauer H. Studies on the activation by ATP of the 26S proteasome complex from rat skeletal muscle. Biochem. J. 309 (1995) 195-202
22. Dardevet D., Sornet C., Taillandier D., Savary I., Attaix D., and Grizard J. Sensitivity and protein turnover response to glucorticoids are different in skeletal muscle from adult and old rats. Lack of regulation of the ubiquitin-proteasome proteolytic pathway in aging. J. Clin. Invest. 96 (1995) 2113-2119
23. Dawson S.P., Arnold J.E., Mayer N.J., Reynolds S.E., Billett M.A., Gordon C., Colleaux L., Kloetzel P.M., Tanaka K., and Mayer R.J. Developmental changes of the 26S proteasome in abdominal intersegmental muscles of Manduca sexta during programmed cell death. J. Biol. Chem. 270 (1995) 1850-1858
24. Deveraux Q., Ustrell V., Pickart C., and Rechsteiner M. A 26S protease subunit that binds ubiquitin conjugates. J. Biol. Chem. 269 (1994) 7059-7061
25. Driscoll J., and Goldberg A.L. Skeletal muscle proteasome can degrade proteins in an ATP-dependent process that does not require ubiquitin. Proc. Natl. Acad. Sci. USA 86 (1989) 787-791
26. Dubiel W., Pratt G., Ferrell K., and Rechsteiner M. Purification of an US regulator of the multicatalytic protease. J. Biol. Chem. 267 (1992) 22369-22377
27. Dubiel W., and Rechsteiner M. The 19S regulatory complex of the 26S proteasome. In: Rivett A.J. (Ed). Advances in Molecular and Cell Biology 27 (1998), JAI Press, Greenwich, CT 129-163
28. Duckworth W.C., Bennett R.G., and Hamel F.G. A direct inhibitory effect of insulin on a cytosolic proteolytic complex containing insulin-degrading enzyme and multicatalytic proteinase. J. Biol. Chem. 269 (1994) 24575-24580
29. Ebisui C., Tsujinaka T., Morimoto T., Kan K., Iijima S., Yano M., Kominami E., Tanaka K., and Monden M. Interleukin-6 induces proteolysis by activating intracellular proteases (cathepsins B and L, proteasome) in C2C12 myotubes. Clin. Sci. 89 (1995) 431-439
30. Fagan J.M., Wajnberg E.F., Culbert L., and Waxman L. ATP depletion stimulates calcium-dependent protein breakdown in chick skeletal muscle. Am. J. Physiol. 262 (1992) E637-E643
31. Fagan J.M., and Waxman L. A novel ATP-requiring protease from skeletal muscle that hydrolyzes non-ubiquitinated proteins. J. Biol. Chem. 264 (1989) 17868-17872
32. Fagan J.M., Waxman L., and Goldberg A.L. Skeletal muscle and liver contain a soluble ATP+ubiquitin-dependent proteolytic system. Biochem. J. 243 (1987) 335-343
33. Fang C., Tiao G., James H., Ogle C., Fischer J.E., and Hasselgren P.O. Burn injury stimulates multiple proteolytic pathways in skeletal muscle, including the ubiquitin-energy-dependent pathway. J. Am. Coll. Surg. 180 (1995) 161-170
34. Flores E.A., Bistrian B.R., Pomposelli J.J., Dinarello C.A., Blackburn G.L., and Istfan N.W. Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat A synergistic effect with interleukin 1. J. Clin. Invest. 83 (1989) 1614-1622
35. Forbes G.B. The adult decline in lean body mass. Hum. Biol. 48 (1976) 161-173
36. Furuno K., Goodman M.N., and Goldberg A.L. Role of different proteolytic systems in the degradation of muscle proteins during denervation atrophy. J. Biol. Chem. 265 (1990) 8550-8557
37. Garcia-Martinez C., Agell N., Llovera M., Lopez-Soriano F.J., and Argiles J.M. Tumour necrosis factor-α increases the ubiquitinization of rat skeletal muscle proteins. FEBS Lett. 323 (1993) 211-214
38. Garcia-Martinez C., Llovera M., Agell N., Lopez-Soriano F.J., and Argiles J.M. Ubiquitin gene expression in skeletal muscle is increased during sepsis: Involvement of TNF-α, but not IL-1. Biochem. Biophys. Res. Commun. 217 (1995) 839-844
39. Goldspink D.F., Morton P.A.J., Loughna P., and Goldspink G. The effect of hypokinesia and hypodynamia on protein turnover and the growth of four skeletal muscles of the rat. Pflügers Arch. 407 (1986) 333-340
40. Goll D.E., Thompson V.F., Taylor R.G., and Zalewska T. Is calpain activity regulated by membranes and autolysis or by calcium and calpastatin?. Bioessays 14 (1992) 549-556
41. Gonen H., Stancovski I., Shkedy D., Hadari T., Bercovich B., Bengal E., Mesilati S., Abu-Atoum O., Schwartz A.L., and Ciechanover A. Isolation, characterization, and partial purification of a novel ubiquitin-protein ligase, E3. J. Biol. Chem. 271 (1996) 302-310
42. Goodman M.N. Interleukin-6 induces skeletal muscle protein breakdown in rats. Proc. Soc. Exp. Biol. Med. 205 (1994) 182-185
43. 1, is required for stress-induced lysosomal degradation of cellular proteins. J. Biol. Chem. 266 (1991) 3602-3610
44. Handley P.M., Mueckler M., Siegel N.R., Ciechanover A., and Schwartz A.L. Molecular cloning, sequence, and tissue distribution of the human ubiquitin-activating enzyme E1. Proc. Natl. Acad. Sci. USA 88 (1991) 258-262
45. Haas A.L., Baboshina O., Williams B., and Schwartz L.M. Coordinate induction of the ubiquitin conjugation pathway accompanies the developmentally programmed death of insect skeletal muscle. J. Biol. Chem. 270 (1995) 9407-9412
46. Haas A.L., and Riley D.A. The dynamics of ubiquitin pools within skeletal muscle. In: Schlesinger M., and Herskho A. (Eds). The Ubiquitin System (1988), Cold Spring Harbor Laboratory Press, New York 178-185
47. Hasselgren P.O. Protein Metabolism in Sepsis (1993), R. G. Landes Co., Austin
48. Hershko A., and Ciechanover A. The ubiquitin system for protein degradation. Annu. Rev. Biochem. 61 (1992) 761-807
49. Hong D.H., and Forsberg N.E. Effects of dexamefhasone on protein degradation and protease gene expression in rat L8 myotube cultures. Mol. Cell. Endocrinol. 108 (1995) 199-209
50. Ilian M.A., and Forsberg N.E. Gene expression of calpains and their specific endogenous inhibitor, calpastatin, in skeletal muscle of fed and fasted rabbits. Biochem. J. 287 (1992) 163-171
51. 3H1 myocytes require an interaction between glucocorticoids and acidification. Proc. Natl. Acad. Sci. USA 93 (1996) 1967-1971
52. Johnson P. Calpains (intracellular calcium-activated cysteine proteinases): structure-activity relationships and involvement in normal and abnormal cellular metabolism. Int. J. Biochem. 22 (1990) 811-822
53. Jones M.E.E., Haire M.F., Kloetzel P.-M., Mykles D.L., and Schwartz L.M. Changes in the stucture and function of the multicatalytic proteinase (proteasome) during programmed cell death in the intersegmental muscles of the hawkmoth, Manduca sexta. Dev. Biol. 169 (1995) 436-447
54. Kettelhut I.C., Wing S.S., and Goldberg A.L. Endocrine regulation of protein breakdown in skeletal muscle. Diabetes Metab. Rev. 4 (1988) 751-772
55. Knecht E., de Llano U.M., Andreu E.J., and Miralles I.M. Pathways for the degradation of intracellular proteins within lysosomes in higher eukaryotes. In: Rivett A.J. (Ed). Advances in Molecular and Cell Biology 27 (1998), JAI Press, Greenwich, CT 201-234
56. Larbaud D., Debras E., TaiUandier D., Samuels S.E., Temparis S., Champredon C., Grizard J., and Attaix D. Euglycemic hyperinsulinemia and hyperaminoacidemia decrease skeletal muscle ubiquitin mRNA in goats. Am. J. Physiol. 271 (1996) E505-E512
57. Laub M., and Jennissen H.P. Ubiquitination of myosin light chains. Biol. Chem. Hoppe-Seyler 372 (1991) 704
58. Li J.B., and Goldberg A.L. Effects of food deprivation on protein synthesis and degradation in rat skeletal muscles. Am. J. Physiol. 231 (1976) 441-448
59. Li J.B., Higgins J.E., and Jefferson L.S. Changes in protein turnover in skeletal muscle in response to fasting. Am. J. Physiol. 236 (1979) E222-E228
60. Llovera M., Carbo N., Garcia-Martinez C., Costelli P., Tessitore L., Baccino F.M., Agell N., Bagby G.J., Lopez-Soriano F.J., and Argiles J.M. Anti-TNF treatment reverts increased muscle ubiquitin gene expression in tumour-bearing rats. Biochem. Biophys. Res. Commun. 221 (1996) 653-655
61. Llovera M., Garcia-Martinez C., Agell N., Lopez-Soriano F.J., and Argiles J.M. Muscle wasting associated with cancer cachexia is linked to an important activation of the ATP-dependent ubiquitin-mediated proteolysis. Int. J. Cancer 61 (1995) 138-141
62. Llovera M., Garcia-Martinez C., Agell N., Marzabal M., Lopez-Soriano F.J., and Argiles J.M. Ubiquitin gene expression is increased in skeletal muscle of tumour-bearing rats. FEBS Lett. 338 (1994) 311-318
63. Lowell B.B., Ruderman N.B., and Goodman M.N. Evidence that lysosomes are not involved in the degradation of myofibrillar proteins in rat skeletal muscle. Biochem. J. 234 (1986) 237-240
64. MacLennan P.A., McArdle A., and Edwards R.H.T. Effects of calcium on protein turnover of incubated muscles from mdx mice. Am. J. Physiol. 260 (1991) E594-E598
65. 2+-activated and ATP-ubiquitin-dependent proteolytic pathways in skeletal muscle from head trauma patients. Proc. Natl. Acad. Sci., USA 93 (1996) 2714-2718
66. Medina R., Wing S.S., and Goldberg A.L. Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. Biochem. J. 307 (1995) 631-637
67. Medina R., Wing S.S., Haas A., and Goldberg A.L. Activation of the ubiquitin-ATP-dependent proteolytic system in skeletal muscle during fasting and denervation atrophy. Biomed. Biochim. Acta 50 (1991) 347-356
68. Medina R., Wing S.S., Kettelhut I., and Goldberg A.L. Regulation of different proteolytic systems in muscle by insulin and food intake. In: Nair K.S. (Ed). Protein Metabolism in Diabetes Mellitus (1992), Smith Gordon, London 111-123
69. Melloni E., and Pontremoli S. The calpain-calpastatin system: structural and functional properties. J. Nutr. Biochem. 2 (1991) 467-476
70. Millward D.J., Bates P.C., Grimble G.K., Brown J.G., Nathan M., and Rennie M.J. Quantitative importance of non-skeletal-muscle sources of N-methylhistidine in urine. Biochem. J. 190 (1980) 225-228
71. Mitch W.E., and Goldberg A.L. Mechanisms of muscle wasting The role of the ubiquitin-proteasome pathway. N. Engl. J. Med. 335 (1996) 1897-1905
72. Mitch W.E., Medina R., Grieber S., May R.C., England B.K., Price S.R., Bailey J.L., and Goldberg A.L. Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes. J. Clin. Invest. 93 (1994) 2127-2133
73. Molinari M., Anagli J., and Carafoli E. PEST sequences do not influence substrate susceptibility to calpain proteolysis. J. Biol. Chem. 270 (1995) 2032-2035
74. Mortimore G.E., Kadowaki M., and Heydrick S.J. The autophagic pathway in liver: its regulation and role in macromolecular turnover. In: Nair K.S. (Ed). Protein Metabolism in Diabetes Mellitus (1992), Smith Gordon, London 125-138
75. Mykles D.L. Lobster muscle proteasome and the degradation of myofibrillar proteins. Enzyme Protein 47 (1993) 220-231
76. Mykles D.L. Differential effects of bovine PA 28 on six peptidase activities of the lobster muscle proteasome (multicatalytic proteinase). Arch. Biochem. Biophys. 325 (1996) 77-81
77. Mykles D.L., and Haire M.F. Sodium dodecyl sulfate and heat induce two distinct forms of lobster muscle multicatalytic proteinase: the heat-activated form degrades myofibrillar proteins. Arch. Biochem. Biophys. 288 (1991) 543-551
78. Mykles D.L., and Haire M.F. Branched-chain-amino acid-preferring peptidase activity of the lobster multicatalytic proteinase (proteasome) and the degradation of myofibrillar proteins. Biochem. J. 306 (1995) 285-291
79. Pepato M.T., Migliorini R.H., Goldberg A.L., and Kettelhut I.C. Role of different proteolytic pathways in degradation of muscle protein from streptozotocin-diabetic rats. Am. J. Physiol. 271 (1996) E340-E347 1996
80. Pisters P.W.T., and Brennan M.F. Amino acid metabolism in human cancer cachexia. Annu. Rev. Nutr. 10 (1990) 107-132
81. Price S.R., Bailey J.L., Wang X., Jurkovitz C., England B.K., Ding X., Phillips L.S., and Mitch W.E. Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription. J. Clin. Invest. 98 (1996) 1703-1708
82. Price S.R., England B.K., Bailey J.L., Van Vreede K., and Mitch W.E. Acidosis and glucocorticoids concomitantly increase ubiquitin and proteasome subunit mRNA levels in rat muscles. Am. J. Physiol. 267 (1994) C955-C960
83. Rallière C., Tauveron I., Taillandier D., Guy L., Boiteux J.-P., Giraud B., Attaix D., and Thiéblot P. Glucocorticoids do not regulate the expression of proteolytic genes in skeletal muscle from Cushing syndrome patients. J. Clin. Endocrinol. Metab. 82 (1997) 3161-3164
84. Rechsteiner M. Natural substrates of the ubiquitin proteolytic pathway. Cell 66 (1991) 615-618
85. Richard I., Broux O., Allamand V., Fougerousse F., Chiannilkulchai N., Bourg N., Brenguier L., Devaud C., Pasturaud P., Roudaut C., Hillaire D., Passos-Bueno M.-R., Zatz M., Tischfield J.A., Fardeau M., Jackson C.E., Cohen D., and Beckmann J.S. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 81 (1995) 27-40
86. Rivett A.J. Proteasomes: multicatalytic proteinase complexes. Biochem. J. 291 (1993) 1-10
87. Roberts R.G., Redfern C.P.F., and Goodship T.H.J. Changes in the expression of proteolytic enzymes following correction of acidosis in humans with renal failure (1996), Padova, Italy April 12-13, Abstract 1. Abstract Book of the 4th International Symposium on Amino Acid/Protein Metabolism in Health and Disease
88. Rock K.L., Gramm C., Rothstein L., Clark K., Stein R., Dick L., Hwang D., and Goldberg A.L. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78 (1994) 761-771
89. Rogers S., Wells R., and Rechsteiner M. Amino acids sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234 (1986) 364-368
90. Sakamoto K., Sorimachi H., Kinbara K., Tezuka M., Amano S., Yoshizawa T., Sugita H., Ishiura S., and Suzuki K. Quantification of calpain-related molecules by specific PCR amplification and its application to human muscular dystrophy. Biomed. Res. 15 (1994) 337-346
91. Samuels S.E., Taillandier D., Aurousseau E., Cherel Y., Le Maho Y., Arnal M., and Attaix D. Gastrointestinal tract protein synthesis and mRNA levels for proteolytic systems in adult fasted rats. Am. J. Physiol. 271 (1996) E232-E238
92. Scheiwiller E., Guller H.-P., Merryweather J., Scandella C., Maerki W., Zapf J., and Froesch E.R. Growth restoration of insulin-deficient diabetic rats by recombinant human insulin-like growth factor I. Nature (London) 323 (1986) 169-171
93. Semmler J., Gebert U., Eisenhut T., Moeller J., Schonharting M.M., Alléra A., and Endres S. Xanthine derivatives: comparison between suppression of tumour necrosis factor-α production and inhibition of cAMP phosphodiesterase activity. Immunology 78 (1993) S20-S25
94. Smith L.K., Bradshaw M., Croall D.E., and Garner C.W. The insulin receptor substrate (IRS-1) is a PEST protein that is susceptible to calpain degradation in vitro. Biochem. Biophys. Res. Commun. 196 (1993) 767-772
95. Solomon V., and Goldberg A.L. Importance of the ATP-ubiquitin-proteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts. J. Biol. Chem. 271 (1996) 26690-26697
96. Sorimachi H., Imajoh-Ohmi S., Emori Y., Kawasaki H., Ohno S., Minami Y., and Suzuki K. Molecular cloning of a novel mammalian calcium-dependent protease distinct from both m-and mu type: specific expression of the mRNA in skeletal muscle. J. Biol. Chem. 264 (1989) 20106-20111
97. Sorimachi H., Ishiura S., and Suzuki K. Structure and physiological function of calpains. Biochem. J. 328 (1997) 721-732
98. Sorimachi H., Toyama-Sorimachi N., Ishiura S., and Suzuki K. Identification and localization of a novel muscle-specific calpain, p94. In: Bond J.S., and Barrett A.J. (Eds). Proteolysis and Protein Turnover (1993), Portland Press, London 45-49
99. Spencer M.J., Croall D.E., and Tidball J.G. Calpains are activated in necrotic fibers from mdx dystrophic mice. J. Biol. Chem. 270 (1995) 10909-10914
100. Sugden P.H., and Fuller S.J. Regulation of protein turnover in skeletal and cardiac muscle. Biochem. J. 273 (1991) 21-37
101. 2+-activated and ATP-ubiquitin-dependent proteinases in the unweighted rat soleus muscle. Biochem. J. 316 (1996) 65-72
102. Takayanagi K., Dawson S., Reynolds S.E., and Mayer R.J. Specific developmental changes in the regulatory subunits of the 26S proteasome in intersegmental muscles preceding eclosion in Manduca sexta. Biochem. Biophys. Res. Commun. 228 (1996) 517-523
103. Tanaka K., and Tanahashi N. The 20S proteasome: Subunits and functions. In: Rivett A.J. (Ed). Advances in Molecular and Cell Biology 27 (1998), JAI Press, Greenwich, CT 105-128 In press
104. Tawa Jr. N.E., and Goldberg A.L. Protein and amino acid metabolism in muscle. In: Engel A.G., and Franzini-Armstrong C. (Eds). Myology (1994), Mc Graw-Hill, New York 683-707
105. Tawa Jr. N.E., Kettelhut I.C., and Goldberg A.L. Dietary protein deficiency reduces lysosomal and nonlysosomal ATP-dependent proteolysis in muscle. Am. J. Physiol. 263 (1992) E326-E334
106. Tawa Jr. N.E., Odessey R., and Goldberg A.L. Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles. J. Clin. Invest. 100 (1997) 197-203
107. Taylor R.G., Tassy C., Briand M., Robert N., Briand Y., and Ouali A. Proteolytic activity of proteasome on myofibrillar structures. Mol. Biol. Rep. 21 (1995) 71-73
108. Temparis S., Asensi M., Taillandier D., Aurousseau E., Larbaud D., Obled A., Bechet D., Ferrara M., Estrela J.M., and Attaix D. Increased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats. Cancer Res. 54 (1994) 5568-5573
109. Tesseraud S., Grizard J., Debras E., Papet I., Bonnet Y., Bayle G., and Champredon C. Leucine metabolism in lactating and dry goats: effect of insulin and substrate availability. Am. J. Physiol. 265 (1993) E402-E413
110. Thomason D.B., and Booth F.W. Atrophy of the soleus muscle by hindlimb unweighting. J. Appl. Physiol. 68 (1990) 1-12
111. Tiao G., Fagan J.M., Roegner V., Lieberman M., Wang J.J., Fischer J.E., and Hasselgren P.O. Energy-ubiquitin-dependent muscle proteolysis during sepsis is regulated by glucocorticoids. J. Clin. Invest. 97 (1996) 339-348
112. Tiao G., Fagan J.M., Samuels N., James J.H., Hudson K., Lieberman M., Fischer J.E., and Hasselgren P.O. Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle. J. Clin. Invest. 94 (1994) 2255-2264
113. Tischler M., Desautels M., and Goldberg A.L. Does leucine, leucyltRNA or some metabolite of leucine regulate protein synthesis and degradation in skeletal and cardiac muscle?. J. Biol. Chem. 257 (1982) 1613-1621
114. Tischler M.E., Rosenberg S., Satarug S., Henriksen E.J., Kirby C.R., Tome M., and Chase P. Different mechanisms of increased proteolysis in atrophy induced by denervation or unweighting of rat soleus muscle. Metabolism 39 (1990) 756-763
115. Todorov P., Cariuk P., McDevitt T., Coles B., Fearon K., and Tisdale M. Characterization of a cancer cachectic factor. Nature (London) 379 (1996) 739-742
116. Tsujinaka T., Fujita J., Ebisui C., Yano M., Kominami E., Suzuki K., Tanaka K., Katsume A., Ohsugi Y., Shiosaki H., and Monden M. Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. J. Clin. Invest. 97 (1996) 244-249
117. Turner P.R., Westwood T., Regen C.M., and Steinhardt R.A. Increased protein degradation results from elevated free calcium levels found from mdx mice. Nature (London) 335 (1988) 735-738
118. 2+-activated and ubiquitin-proteasome proteolytic pathways. J. Clin. Invest. 97 (1996) 1610-1617
119. Wassner S.J., and Li J.B. N-methylhistidine release: Contributions of rat skeletal muscle, gastrointestinal tract and skin. Am. J. Physiol. 243 (1982) E293-E297
120. Waterlow J.C., Garlick P.J., and Millward D.J. Protein Turnover in Mammalian Tissues and in the Whole Body (1978), Elsevier North Holland, Amsterdam
121. Wefes I., Mastrandrea L.D., Haldeman M., Koury S.T., Tamburlin J., Pickart C.M., and Finley D.L. Induction of ubiquitin-conjugating enzymes during terminal erythroid differentiation. Proc. Natl. Acad. Sci. USA 92 (1995) 4982-4986
122. Wilkinson K.D. Cellular regulation by ubiquitin-dependent processes. In: Rivett A.J. (Ed). Advances in Molecular and Cell Biology 27 (1998), JAI Press, Greenwich, CT 71-104 In press
123. Wing S.S., and Banville D. 14-kDa ubiquitin-conjugating enzyme: structure of the rat gene and regulation upon fasting and by insulin. Am. J. Physiol. 267 (1994) E39-E48
124. Wing S.S., and Bedard N. Insulin-like growth factor I stimulates degradation of a mRNA transcript encoding the 14 kDa ubiquitin-conjugating enzyme. Biochem. J. 319 (1996) 455-461
125. Wing S.S., Chiang A.L., Goldberg A.L., and Dice J.F. Proteins containing peptide sequences related to lys-phe-glu-arg-gln are selectively depleted in liver and heart but not skeletal muscle of fasted rats. Biochem. J. 275 (1991) 165-169
126. Wing S.S., and Goldberg A.L. Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. Am. J. Physiol. 264 (1993) E668-E676
127. Wing S.S., Haas A.L., and Goldberg A.L. Increase in ubiquitin-protein conjugates concomitant with the increase in proteolysis in rat skeletal muscle during starvation and atrophy denervation. Biochem. J. 307 (1995) 639-645
128. 17kB) highly expressed in rat testis. Biochem. J. 305 (1995) 125-132
129. Young V.R., and Munro H.N. Nτ-methylhistidine (3-methylhistidine) and muscle protein turnover: an overview. Fed. Proc. 37 (1978) 2291-2300